NCT06644755 2025-07-24First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsDaiichi SankyoPhase 1 Recruiting150 enrolled
NCT03874455 2024-03-22Tazemetostat Expanded Access Program for Adults With Solid TumorsIpsenNo longer available
NCT03132922 2024-01-22MAGE-A4ᶜ¹º³²T for Multi-TumorAdaptimmunePhase 1 Active not recruiting71 enrolled
NCT03638206 2019-12-11Autologous CAR-T/TCR-T Cell Immunotherapy for MalignanciesShenzhen BinDeBio Ltd.Phase 1/2 Unknown73 enrolled
NCT00154388 2016-11-18Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare DiseasesNovartisPhase 2 Completed185 enrolled